 |
|
(i-REH-suh)
| | A drug that is used to treat certain types of non-small cell lung cancer and is being studied in the treatment of other types of cancer. It is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called ZD1839 and gefitinib. |
| Previous Definitions: | IP, IP6, ipilimumab, ipsilateral, IRB | | Next Definitions: | irinotecan, iris, irofulven, iron, irradiated |
|
|
